These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10719438)

  • 1. Treatment of arterial hypertension in the elderly using enalapril.
    Terranova R; Luca S; Calanna A
    Minerva Med; 1999 Sep; 90(9):333-7. PubMed ID: 10719438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of long-term uncontrolled antihypertensive therapy on the echocardiographic signs of left-heart hypertrophy in patients with mild and moderate arterial hypertension].
    Lerman OV; Metelitsa VI; Filatova NP; Duda SG; Malysheva NV; Vygodin VA
    Ter Arkh; 1997; 69(1):43-6. PubMed ID: 9163049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A decrease in left ventricular hypertrophy and the dynamics of the parameters of circadian BP monitoring under the influence of ramipril in patients with essential arterial hypertension].
    Pekarskiĭ SE; Vorozhtsova IN; Mordovin VF
    Ter Arkh; 1997; 69(4):18-20. PubMed ID: 9213948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
    Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
    González-Juanatey JR; Reino AP; García-Acuña JM; Varela Román A; Calvo Gómez C; Cabezas-Cerrato J
    Am J Cardiol; 1998 Jan; 81(1):87-90. PubMed ID: 9462614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR; Pose Reino A; Román AV; García Acuña JM; Fernández López JA; Cerrato JC
    Am J Cardiol; 1997 Feb; 79(3):373-6. PubMed ID: 9036764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).
    Devereux RB; Dahlof B; Levy D; Pfeffer MA
    Am J Cardiol; 1996 Jul; 78(1):61-5. PubMed ID: 8712120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
    González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
    Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
    Ribstein J; Du Cailar G; Brouard R; Mimran A
    Cardiology; 1993; 83 Suppl 1():57-63. PubMed ID: 7903217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance.
    Leonetti G; Fogari R; Mazzola C; Pasotti C; Ponti GB; Marelli C; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S356-7. PubMed ID: 8158420
    [No Abstract]   [Full Text] [Related]  

  • 16. [The regression of the structural-functional changes in the hypertrophic left ventricle during the long-term correction of the arterial pressure with Inhibace (cilazapril)].
    Gurochkin AB; Ivleva AIa; Kobavlava ZhD; Moiseev VS
    Ter Arkh; 1994; 66(9):46-9. PubMed ID: 7992212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of antihypertensive therapy on left ventricular mass and diastolic filling in light and moderate hypertension].
    Salcedo A; Lekuona I; Laraudogoitia E; Echevarría P; Madariaga JA; Palomar S; Zumalde J; Barrenetxea JI
    Med Clin (Barc); 1993 May; 100(17):646-50. PubMed ID: 8497169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the regression of left ventricular hypertrophy and the changes in circadian blood pressure after long-term treatment with enalapril in hypertensive patients.
    Horio T; Kohno M; Yasunari K; Murakawa K; Yokokawa K; Ikeda M; Fukui T; Kano H; Takeda T
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):177-82. PubMed ID: 8032577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
    Motz W; Strauer BE
    Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.